GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Sarepta Therapeutics Inc (SRPT) [hlAlert]

Rating:
Buy SRPT
up 43.48 %

Sarepta Therapeutics Inc (SRPT) rated Buy by BofA/Merrill

Posted on: Friday,  Oct 23, 2015  10:25 AM ET by BofA/Merrill

BofA/Merrill rated Buy Sarepta Therapeutics Inc (NASDAQ: SRPT) on 10/23/2015, when the stock price was $25.25. Since
then, Sarepta Therapeutics Inc has gained 43.49% as of 01/19/2016's recent price of $36.23.
If you would have followed this BofA/Merrill's recommendation on SRPT, you would have gained 43.48% of your investment in 88 days.

AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using third-generation NEUGENE antisense drugs and ESPRIT exon skipping technology. AVI's lead NEUGENE antisense compound is designed to target cell proliferation disorders, including cardiovascular restenosis. In addition to targeting specific genes in the body, AVI's antiviral program uses NEUGENE antisense compounds to combat disease by targeting single-stranded RNA viruses, including West Nile virus, hepatitis C virus, dengue virus, Ebola virus and influenza A virus. AVI's NEUGENE-based ESPRIT technology will initially be applied to potential treatments for Duchenne muscular dystrophy.

BofA/Merrill
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/23/2015 10:25 AM Buy
None
25.25
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy